FtsZ: A Novel Target for Tuberculosis Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|5|527-543

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.5, 2007-03, pp. : 527-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Navigating tuberculosis drug discovery with target-based screening

By Miller Christopher H   O'Toole Ronan F  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 839-854

Informa Healthcare

Access to resources Recommend Favorite

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

The Synthesis and Antibacterial Activity of Novel 3-O-arylalkylbenzamide Derivatives as FtsZ Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 4, 2013-01 ,pp. : 320-326

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

By Sharma Anshika   Khuller Gopal K   Sharma Sadhna  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite

DprE1 – from the Discovery to the Promising Tuberculosis Drug Target

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4379-4403

Bentham Science Publishers

Access to resources Recommend Favorite